BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 30109347)

  • 1. Some activities of PorphyChem illustrated by the applications of porphyrinoids in PDT, PIT and PDI.
    Habermeyer B; Guilard R
    Photochem Photobiol Sci; 2018 Nov; 17(11):1675-1690. PubMed ID: 30109347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyrinoid biohybrid materials as an emerging toolbox for biomedical light management.
    Almeida-Marrero V; van de Winckel E; Anaya-Plaza E; Torres T; de la Escosura A
    Chem Soc Rev; 2018 Oct; 47(19):7369-7400. PubMed ID: 30152500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorin, Phthalocyanine, and Porphyrin Types Derivatives in Phototreatment of Cutaneous Manifestations: A Review.
    De Annunzio SR; Costa NCS; Mezzina RD; Graminha MAS; Fontana CR
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments.
    Garland MJ; Cassidy CM; Woolfson D; Donnelly RF
    Future Med Chem; 2009 Jul; 1(4):667-91. PubMed ID: 21426032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of porphyrin chemistry in tumor imaging and photodynamic therapy.
    Ethirajan M; Chen Y; Joshi P; Pandey RK
    Chem Soc Rev; 2011 Jan; 40(1):340-62. PubMed ID: 20694259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy: Dermatology and ophthalmology as main fields of current applications in clinic.
    Silva JN; Filipe P; Morlière P; Mazière JC; Freitas JP; Gomes MM; Santus R
    Biomed Mater Eng; 2008; 18(4-5):319-27. PubMed ID: 19065042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy efficacy enhanced by dynamics: the role of charge transfer and photostability in the selection of photosensitizers.
    Arnaut LG; Pereira MM; Dąbrowski JM; Silva EF; Schaberle FA; Abreu AR; Rocha LB; Barsan MM; Urbańska K; Stochel G; Brett CM
    Chemistry; 2014 Apr; 20(18):5346-57. PubMed ID: 24644142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy.
    Rkein AM; Ozog DM
    Dermatol Clin; 2014 Jul; 32(3):415-25, x. PubMed ID: 24891062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyrins in photodynamic therapy - a search for ideal photosensitizers.
    Pushpan SK; Venkatraman S; Anand VG; Sankar J; Parmeswaran D; Ganesan S; Chandrashekar TK
    Curr Med Chem Anticancer Agents; 2002 Mar; 2(2):187-207. PubMed ID: 12678743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy in dermatology.
    Steinbauer JM; Schreml S; Kohl EA; Karrer S; Landthaler M; Szeimies RM
    J Dtsch Dermatol Ges; 2010 Jun; 8(6):454-64. PubMed ID: 20136674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Cellular Uptake and Photodynamic Effect with Amphiphilic Fluorinated Porphyrins: The Role of Sulfoester Groups and the Nature of Reactive Oxygen Species.
    Pucelik B; Sułek A; Drozd A; Stochel G; Pereira MM; Pinto SMA; Arnaut LG; Dąbrowski JM
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photosensitizers for Photodynamic Therapy.
    Lan M; Zhao S; Liu W; Lee CS; Zhang W; Wang P
    Adv Healthc Mater; 2019 Jul; 8(13):e1900132. PubMed ID: 31067008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The translocator protein as a potential molecular target for improved treatment efficacy in photodynamic therapy.
    Rogers L; Senge MO
    Future Med Chem; 2014 May; 6(7):775-92. PubMed ID: 24941872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Photosensitizers in Semisolid Formulations for Microbial Photodynamic Inactivation.
    González-Delgado JA; Kennedy PJ; Ferreira M; Tomé JP; Sarmento B
    J Med Chem; 2016 May; 59(10):4428-42. PubMed ID: 26569024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin.
    Calzavara-Pinton PG; Venturini M; Sala R
    J Photochem Photobiol B; 2005 Jan; 78(1):1-6. PubMed ID: 15629243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and photodynamic activity of novel non-symmetrical diaryl porphyrins against cancer cell lines.
    Caruso E; Cerbara M; Malacarne MC; Marras E; Monti E; Gariboldi MB
    J Photochem Photobiol B; 2019 Jun; 195():39-50. PubMed ID: 31075653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phthalocyanines covalently bound to biomolecules for a targeted photodynamic therapy.
    Taquet JP; Frochot C; Manneville V; Barberi-Heyob M
    Curr Med Chem; 2007; 14(15):1673-87. PubMed ID: 17584072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-MYC and C-FOS expression changes and cellular aspects of the photodynamic reaction with photosensitizers TMPyP and ClAlPcS2.
    Pizova K; Bajgar R; Fillerova R; Kriegova E; Cenklova V; Langova K; Konecny P; Kolarova H
    J Photochem Photobiol B; 2015 Jan; 142():186-96. PubMed ID: 25545333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New photosensitizers for photodynamic therapy.
    Abrahamse H; Hamblin MR
    Biochem J; 2016 Feb; 473(4):347-64. PubMed ID: 26862179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in photodynamic therapy. A review.
    Ortel B; Calzavara-Pinton P
    G Ital Dermatol Venereol; 2010 Aug; 145(4):461-75. PubMed ID: 20823790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.